Overweight and obesity. Obesity, unspecified
Conditions
Interventions
Intervention 1: Intervention group 1: Participants will receive daily chlorella vulgaris supplement provided by the Iranian's Green Future company (900 mg/day in 300 mg pills after three main meals) a
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Tendency and the ability of cooperation The age range of 18 to 35 BMI in the range of overweight to type 1 obesity (25-34.9)
Exclusion criteria
Exclusion criteria: Joint and bone disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anthropometric measures. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Measurement of height and weight without shoes and with minimum clothes on, by Seca stadiometer and scale, respectively. Measurement of waist and hip circumferences by a tape measure. Calculation of waist to hip ratio (WHR) by dividing waist circumference by hip circumference, and body mass index (BMI) by dividing weight (Kg) by height squared (m2).;Body composition. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Bioelectrical Impedance Analysis (BIA) to determine Fat mass (FM), Fat free mass (FFM), and Body water (BW).;Resting metabolic rate. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Indirect calorimetry.;Blood pressure. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: It is done using a medical barometer.;Heart rate. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: It is done using a digital barometer.;Blood glucose. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Enzymatic method.;Lipid profile. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Measurement of total cholesterol, HDL-cholesterol and triglyceride through enzymatic methods and calculation of LDL-cholesterol by Friedewald equation.;Blood insulin. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELISA.;Insulin resistance. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: By the use of formula.;SIRT1. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELISA.;FGF21. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELISA.;PGC-1alpha. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELISA.;Serum Irisin. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELISA.;Total antioxidant capacity. Timepoint: | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahzad Sanayei
Tabriz University of Medical Sciences
Outcome results
None listed